CDK7 and lung carcinoma: Yang (17) used gene chip technology to screen the differentially expressed genes in cisplatin-resistant lung adenocarcinoma cells and found that CDK7 was highly expressed, suggesting that CDK7 is associated with cisplatin resistance in lung carcinomas.